NEWTON, Mass.----Clinical Data, Inc. today announced positive results in its pivotal Phase III study of its investigative compound Vilazodone. In the study, the primary and supportive secondary efficacy endpoints were met.
From: biz.yahoo.com
Clinical Data Announces Positive Results from Phase III Pivotal Trial of Vilazodone for Depression
Posted by Ruslan Abuzant at 6:03 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment